The global Dual and Multi-energy Computed Tomography (CT) market is set for significant growth, with its valuation expected to increase from USD 1.5 billion in 2022 to USD 2.6 billion by 2029. This growth corresponds to an impressive compound annual growth rate (CAGR) of 8.2%, highlighting the rising demand for advanced imaging technologies in the medical field.
Dual and multi-energy CT technologies offer enhanced diagnostic capabilities by providing detailed tissue characterization and improved image quality. These innovations are increasingly being adopted in various medical applications, including oncology, cardiology, and musculoskeletal imaging. As healthcare providers seek more precise and efficient diagnostic tools, these technologies are becoming essential for accurate disease detection and treatment planning.
Key factors driving the market’s growth include technological advancements in CT scanning systems, growing demand for non-invasive imaging solutions, and the rising prevalence of chronic diseases that require detailed imaging. Additionally, the increasing focus on personalized medicine and early disease detection is fueling the adoption of advanced CT technologies in clinical settings.
As the market evolves, key players are investing in developing more sophisticated dual and multi-energy CT systems, further enhancing their diagnostic potential. The continued advancements in these imaging technologies are poised to revolutionize healthcare, making the dual and multi-energy CT market a key area of growth in the medical imaging sector.
Key Growth Drivers
- Technological Advancements: Continuous improvements in dual and multi-energy CT technologies enhance diagnostic capabilities, making them more effective for various medical applications.
- Increasing Incidence of Chronic Diseases: The rising prevalence of conditions such as cancer, cardiovascular diseases, and neurological disorders drives demand for advanced imaging solutions.
- Aging Population: The growing elderly population, which requires more frequent diagnostic imaging, is a significant factor contributing to market growth.
Competitive Landscape
Dual and multi-energy CT equipment suppliers are focusing on performing rigorous research on conventional methods. While existing clinical techniques mainly describe material separation, ongoing research activities consist of abdominal imaging, which include detection and stratification of liver steatosis and fibrosis.
Due to increase in the incidence of injuries and diseases, such as cancer and orthopaedic disorders, among others, various governments in developed countries are actively funding R&D activities to develop cost-effective and efficient medical devices.
For instance,
- John M. Boone, a UC Davis medical physicist and professor of radiology, was awarded a USD 2.88 million grant from the National Cancer Institute to further develop and research computed tomography to detect breast cancer. By increasing the performance of breast cancer screening in a practical and cost-efficient manner, the government is trying to improve care and increase survival in women suffering from the disease, and most importantly, also to reduce over-treatment of women with benign findings.
Key Companies Profiled
Koninklijke Philips N.V. GE Healthcare; Siemens Healthineers; Canon Medical Systems; Fujifilm Holdings Corporation; Shimadzu Corporation; Koning Corporation; Neusoft Medical Systems Co. Ltd; CareStream Health; Planmeca Group; Hitachi Healthcare Systems; Stryker Corporation
Get Complete Full Report
Key Segments of Dual and Multi-Energy CT Industry Research
By Product:
- Rapid kVp Switching
- Energy-Sensitive Sandwich Detectors
- Dual-Source CT
By Clinical Application:
- Virtual Mono-energetic Imaging
- CT Angiography
- Perfused Blood Volume
- Virtual Non-contrast-enhanced Images
- Atherosclerotic Plaque Removal
- Virtual Non-calcium Images
- Urinary Stone Characterization
- Crystalline Arthropathies
- Others
By End User:
- Hospitals
- Diagnostic Centers
- Ambulatory Surgical Centers
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia & Pacific
- Middle East & Africa (MEA)
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
